Fundraising Fox

Arecor

3 known investors

arecor.com ↗

Arecor develops proprietary therapeutics for diabetes and other cardiometabolic diseases using its Arestat formulation and drug delivery technology platform. It also partners with pharmaceutical and medtech companies to improve therapeutic profiles.

BiotechDeep Tech

Investors · 3

AlbionVCLondon
Calculus Capital Ltd.London · $2.5M
Seneca PartnersHaydock

In the news

Skye Bioscience Acquires Redx Pharma, Exits Obesity for Fibrosis Focusclinicaltrialvanguard.com · Aug 2026Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292globenewswire.com · Sep 2025Arecor Therapeutics raises £6.4 million via a placing, subscription and retail offer - Perivanperivan.com · Jul 2024Arecor Therapeutics shares tank on funding update - Sharecast.comsharecast.com · Jun 2024Financial Information - Arecorarecor.com · Nov 2021Biopharma Company Arecor raises £6m for revolutionary diabetes treatments - BioSpacebiospace.com · Sep 2018

Frequently asked questions

What does Arecor do?
Arecor develops proprietary therapeutics for diabetes and other cardiometabolic diseases using its Arestat formulation and drug delivery technology platform. It also partners with pharmaceutical and medtech companies to improve therapeutic profiles.
Who are Arecor's investors?
Arecor's investors include AlbionVC, Calculus Capital Ltd., Seneca Partners.